In light of the general impact of NMDA receptors and NOS enzymes on neuronal functions and synaptic plasticity mechanisms, it is, however, clear that described changes could contribute towards age-dependent deficit in synaptic plasticity and cognitive decline, with implications for pathobiology of AD and neurodegenerative process. This evidence concerns the gene NOS2 and Alzheimer disease.